The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
The innovation -- UPM Circular Renewable Black -- is the world’s first bio-based, near-infrared (NIR) detectable, carbon-negative black
This is the first approval of a prescription transdermal dosage Form in the European markets from this facility
The new centre brings advanced corneal procedures pioneered in India
The company will respond to the US FDA within the stipulated timelines
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
Expands bioprocessing footprint across Asia
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
Subscribe To Our Newsletter & Stay Updated
